Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials

BACKGROUND: This study compared response rates and outcomes of combined radiotherapy and immunotherapy (iRT) based on the type of checkpoint inhibitor (anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) vs antiprogrammed death-1 (PD1)) for metastatic non-small cell lung cancer (mNSCLC). METHOD...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Immunother Cancer
Auteurs principaux: Chen, Dawei, Menon, Hari, Verma, Vivek, Guo, Chunxiao, Ramapriyan, Rishab, Barsoumian, Hampartsoum, Younes, Ahmed, Hu, Yun, Wasley, Mark, Cortez, Maria Angelica, Welsh, James
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2020
Sujets:
Short Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057428/
https://ncbi.nlm.nih.gov/pubmed/31996395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000492
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires